metastatic castration-resistant prostate cancer | European Journal of Clinical and Experimental Medicine

Survival outcome and prognostic factors in patients with chemotherapy-naive metastatic castration-resistant prostate cancer treated with abiraterone acetate – real-world experience in Vietnam

Language English